Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of EVMN will decline by -21.29% over the next 2 Weeks and hit $14.36 by Friday, January 2, 2026. In that time frame, EVMN's share price is expected to range between $13.25 and $15.66.
BearishAverageBullishEVMN shares fell -6.25% in Monday, December 22, 2025's trading session, dropping from a previous close of $18.25 to move at $17.11. The stock demonstrated notable intraday movement (see EVMN's key stats for a full breakdown), fluctuating between $16.40 and $17.90, a +9.15% trading range. While recent weeks have seen some volatility, EVMN has managed to secure a -7.21% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 188.06K shares changing hands, 182.32K fewer than the previous session. This amounted to $3.22M in total market activity.
Will EVMN Continue Its Upward Trend?
According to analyst ratings and projections for EVMN, Evommune, Inc. shares are anticipated to increase by +8.81%, potentially reaching $18.76 per share by January 5, 2026. Short-term technical indicators currently suggest a bearish sentiment for EVMN. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the EVMN stock forecast, now is a good time to buy EVMN stock because its current trading price is +0.92% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on EVMN covering social and institutional perspectives.
EVMN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into EVMN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.96% to 63.93%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase.Insights into EVMN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Evommune Short-Term Forecasts
EVMN Forecast For Next 5 Days
Our algorithm anticipates Evommune (EVMN) stock could hit $16.25 by Dec 29, 2025. This represents a -5.02% fall from today's price, following a -5.00% change over the past five days.
EVMN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Evommune, Inc. (EVMN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $17.04, which would mean a -0.41% decrease from the current price of $17.11. Projections for this period range from a high of $19.90 to a low of $13.81.
EVMN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Evommune's price over the next three months point to a rise. EVMN stock is expected to peak at $131.32 on Mar 12, 2026 before potentially dipping to $0.00 on Mar 20, 2026. On average, EVMN is likely to trade around $30.87 in the coming 90 days.
Evommune Stock Forecast 2025
Based on our predictive models, Evommune (EVMN) is expected to trade between $7.07 and $23.50 throughout 2025. This would result in an average price of $18.18, potentially offering investors a +6.25% return from current levels.
Evommune, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in December 2025. The price is predicted to move between $7.07 and $23.50, settling at an average of $18.18. This could translate to a +6.25% gain.
January 2026
Based on current market signals, Evommune, Inc. is projected to trend january 2026. We forecast a trading range from $0.00 to $104.66, with a likely average price of $21.28. Investors could expect a potential return of +24.37%.
February 2026
Our predictive algorithms indicate Evommune, Inc. stock may see a shift in February 2026. The expected range spans $0.00–$96.38, with an average target of $38.98. This represents a positive outlook and a possible gain of +127.82%.
March 2026
Analyzing established trends, Evommune, Inc. looks set to move in March 2026. Projections place the stock between $0.00 and $131.32, averaging around $27.30. This suggests a +59.56% gain from current levels.
April 2026
Market indicators suggest Evommune, Inc. could experience notable changes during April 2026. Prices could fluctuate within $0.00 to $26.31, with a midpoint forecast of $20.99. The stock might deliver a +22.68% gain.
May 2026
Forecasting for May 2026, models estimate that Evommune, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $15.42 and $26.44, averaging $21.60. This signals a positive trajectory with potential returns around +26.24%.
June 2026
According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $104.25, settling at an average of $21.83. This could translate to a +27.59% gain.
July 2026
Based on current market signals, Evommune, Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $97.56, with a likely average price of $34.27. Investors could expect a potential return of +100.29%.
August 2026
Our predictive algorithms indicate Evommune, Inc. stock may see a shift in August 2026. The expected range spans $0.00–$127.83, with an average target of $27.54. This represents a positive outlook and a possible gain of +60.96%.
September 2026
Analyzing established trends, Evommune, Inc. looks set to move in September 2026. Projections place the stock between $12.99 and $26.04, averaging around $23.04. This suggests a +34.66% gain from current levels.
October 2026
Market indicators suggest Evommune, Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $25.25, with a midpoint forecast of $17.33. The stock might deliver a +1.29% gain.
November 2026
Forecasting for November 2026, models estimate that Evommune, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $94.77, averaging $24.38. This signals a positive trajectory with potential returns around +42.49%.
December 2026
According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $92.08, settling at an average of $42.59. This could translate to a +148.92% gain.
EVMN's history of dividends and stock splits also plays a role in long-term investor confidence.

